The expression levels of CD68, CD163, and CD206 in the BMB samples of CML patients were significantly increased in different phases with disease progression, especially in the CML-BP group which was infiltrated with highest frequency of macrophages (Table 2, Figure 4), when compared to that of control group. The gene discussed is CD163; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.